Multivariable analysis of prognostic factors
| Covariate . | CIR P . | DFS P . | OS P . |
|---|---|---|---|
| MRD (high vs low risk) | .0030 | .0020 | .020 |
| Treatment (risk directed vs not risk directed) | .026 | .036 | .037 |
| KIT (mutation vs wild type) | .049 | NS | NS |
| BM blasts (≥50% vs <50%) | NS | NS | NS |
| WBC (≥20 vs <20) | NS | NS | NS |
| CD56 (positive vs negative) | NS | NS | NS |
| Age (<35 vs ≥35 years old) | NS | NS | NS |
| CR (1 vs >1 course) | NS | NS | NS |
| Cytogenetic (with vs without additional changes) | NS | NS | NS |
| Covariate . | CIR P . | DFS P . | OS P . |
|---|---|---|---|
| MRD (high vs low risk) | .0030 | .0020 | .020 |
| Treatment (risk directed vs not risk directed) | .026 | .036 | .037 |
| KIT (mutation vs wild type) | .049 | NS | NS |
| BM blasts (≥50% vs <50%) | NS | NS | NS |
| WBC (≥20 vs <20) | NS | NS | NS |
| CD56 (positive vs negative) | NS | NS | NS |
| Age (<35 vs ≥35 years old) | NS | NS | NS |
| CR (1 vs >1 course) | NS | NS | NS |
| Cytogenetic (with vs without additional changes) | NS | NS | NS |
BM, bone marrow.